Abcuro Inc. has raised a $200 million Series C financing to fund late-stage development and support commercial launch ...

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

Big funding rounds for software developer Helsing and drone maker Tekever defy broader downturn in venture investing ...

Welcome to Startups Weekly — your weekly recap of everything you can’t miss from the world of startups. Want it in your inbox ...

The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...

The IXP Lifesciences Catalyst Fund has a greenshoe option of Rs 100 crore with an investment horizon of 3-5 years targeting ...

A look at the M&A and stock market pictures for full-year 2024—and the potential strategic implications for pharma and ...

Biotechnology is a rapidly evolving sector with significant advancements anticipated between 2025 and 2035. As innovations in ...

What are "indirect costs" for universities? Why are some young scientists looking at opportunities abroad? And why are AI ...

While billions pour into pharmaceutical biotech, officials and experts warn there’s much less private investment in products more relevant to the military, like body armor materials, anti-corrosion ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.